News Column

Vertex to Present at the Goldman Sachs Global Healthcare Conference on June 10

June 16, 2014

By a News Reporter-Staff News Editor at Pharma Business Week -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 10 at 11:00 a.m. ET (see also Biotechnology Companies).

Management's remarks can be accessed live through Vertex's website at in the "Investors" section under the "Events and Presentations" link. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. A replay of the webcast will also be archived on the company's website for a period of two weeks following the presentation. About Vertex Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For four years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit


Keywords for this news article include: Vertex Pharmaceuticals Incorporated, Industry, Goldman Sachs, Financial Companies, Investment Companies, Biotechnology Companies, Biopharmaceutical Companies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Pharma Business Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters